Targeting the gut vascular endothelium induces gut effector CD8 T cell responses via cross-presentation by dendritic cells

Journal of Immunology

Volumn 179, Issue 9, 2007, Pages 5678-5685

  Bourges, Dorothee ^a   Zhan, Yifan ^a   Brady, Jamie L ^a   Braley, Hal ^a   Caminschi, Irina ^a   Prato, Sandro ^a   Villadangos, José A ^a   Lew, Andrew M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; ANTIGEN; CELL ADHESION MOLECULE; GLYCOPROTEIN P 15095; HLA ANTIGEN CLASS 1; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B CELL LYMPHOMA; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; INTESTINE CELL; INTESTINE LYMPHATIC TISSUE; LYMPHOID TISSUE; MESENTERY LYMPH NODE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VENULE; ANIMAL; B CELL LEUKEMIA; CELL CULTURE; CROSS PRESENTATION; IMMUNOLOGY; INTESTINE; LYMPH NODE; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS; ANTIGENS, CD11C; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL PROLIFERATION; CELLS, CULTURED; CROSS-PRIMING; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTESTINES; LEUKEMIA, B-CELL; LYMPH NODES; MICE; MICE, TRANSGENIC; OVALBUMIN;

EID: 38449114577     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.9.5678     Document Type: Article

References (40)

1. Czerkinsky, C., F. Anjuere, J. R. McGhee, A. George-Chandy, J. Holmgren, M. P. Kieny, K. Fujiyashi, J. F. Mestecky, V. Pierrefite-Carle, C. Rask, and J. B. Sun. 1999. Mucosal immunity and tolerance: relevance to vaccine development. Immunol. Rev. 170: 197-222.
2. Eriksson, K., and J. Holmgren. 2002. Recent advances in mucosal vaccines and adjuvants. Curr. Opin. Immunol. 14: 666-672.
3. Williams, I. R. 2004. Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol. Res. 29: 283-292.
4. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11: S45-S53.
5. Kunkel, E. J., and E. C. Butcher. 2003. Plasma-cell homing. Nat. Rev. Immunol. 3: 822-829.
6. Butcher, E. C. 1999. Lymphocyte homing and intestinal immunity. In Mucosal Immunology, 2nd edition. P. L. Orga, J. Mestecky, M. E. Lamm, W. Strober, J. Bienestock, J. R. McGhee, eds. Academic Press, San Diego, pp. 507-522.
7. Campbell, D. J., C. H. Kim, and E. C. Butcher. 2003. Chemokines in the systemic organization of immunity. Immunol. Rev. 195: 58-71.
8. Quiding, M., I. Nordström, A. Kilander, G. Andersson, L. A. Hanson, J. Holmgren, and C. Czerkinsky. 1991. Intestinal immune responses in humans: oral cholera vaccination induces strong intestinal antibody responses and interferon-γ production and evokes local immunological memory. J. Clin. Invest. 88: 143-148.
9. Briskin, M., D. Winsor-Hines, A. Shyjan, N. Cochran, S. Bloom, J. Wilson, L. M. McEvoy, E. C. Butcher, N. Kassam, C. R. Mackay, et al. 1997. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151: 97-110.
10. Streeter, P. R., E. L. Berg, B. T. Rouse, R. F. Bargatze, and E. C. Butcher. 1988. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 331: 41-46.
11. 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74: 185-195.
12. + T-lymphocyte responses in blood and mucosa during chronic infection. J. Virol. 79: 4289-4297.
13. Nannini, E. C., and P. C. Okhuysen. 2002. HIV1 and the gut in the era of highly active antiretroviral therapy. Curr. Gastroenterol. Rep. 4: 392-398.
14. McKenzie, B. S., A. J. Corbett, S. Johnson, J. L. Brady, J. Pleasance, D. R. Kramer, J. S. Boyle, D. C. Jackson, R. A. Strugnell, and A. M. Lew. 2004. Bypassing luminal barriers, delivery to a gut addressin by parenteral targeting elicits local IgA responses. Int. Immunol. 16: 1613-1622.
15. + T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
16. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986.
17. Mannering, S. I., J. S. Morris, K. P. Jensen, A. W. Purcell, M. C. Honeyman, P. M. van Endert, and L. C. Harrison. 2003. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J. Immunol. Methods 283: 173-183.
18. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538.
19. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90: 8392-8396.
20. - dendritic cell subset induces humoral immunity in the absence of conventional "danger". Eur. J. Immunol. 35: 2815-2825.
21. Choi, J., D. R. Enis, K. P. Koh, S. L. Shiao, and J. S. Pober. 2004. T lymphocyte-endothelial cell interactions. Annu. Rev. Immunol. 22: 683-709.
22. Nikolic-Zugic, J., and M. J. Bevan. 1990. Role of self-peptides in positively selecting the T-cell repertoire. Nature 344: 65-67.
23. + dendritic cells. J. Immunol. 166: 5327-5330.
24. Li, M., G. M. Davey, R. M. Sutherland, C. Kurts, A. M. Lew, C. Hirst, F. R. Carbone, and W. R. Heath. 2001. Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J. Immunol. 166: 6099-6103.
25. Zinkernagel, R. M. 2003. On natural and artificial vaccinations. Annu. Rev. Immunol. 21: 515-546.
26. Hanninen, A., A. Braakhuis, W. R. Heath, and L. C. Harrison. 2001. Mucosal antigen primes diabetogenic cytotoxic T-lymphocytes regardless of dose or delivery route. Diabetes 50: 771-775.
27. + T cell response. J. Exp. Med. 201: 1555-1565.
28. Van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2: 423-429.
29. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839.
30. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2: 415-422.
31. Curtsinger, J. M., C. M. Johnson, and M. F. Mescher. 2003. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171: 5165-5171.
32. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
33. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
34. Rothermel, A. L., Y. Wang, J. Schechner, B. Mook-Kanamori, W. C. Aird, J. S. Pober, G. Tellides, and D. R. Johnson. 2004. Endothelial cells present antigens in vivo. BMC Immunol. 5: 5.
35. Marelli-Berg, F. M., and S. J. Jarmin. 2004. Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking? Immunol. Lett. 93: 109-113.
36. + T cells and trigger acute rejection: an alternative mechanism of allorecognition. Nat. Med. 8: 233-239.
37. + T cells. J. Exp. Med. 197: 643-656.
38. Bagai, R., A. Valujskikh, D. H. Canaday, E. Bailey, P. N. Lalli, C. V. Harding, and P. S. Heeger. 2005. Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a. J. Immunol. 174: 7711-7715.
39. Sixt, M., N. Kanazawa, M. Selg, T. Samson, G. Roos, D. P. Reinhardt, R. Pabst, M. B. Lutz, and L. Sorokin. 2005. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22: 19-29.
40. Gretz, J. E., C. C. Norbury, A. O. Anderson, A. E. Proudfoot, and S. Shaw. 2000. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192: 1425-1440.